Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Abstract Contemporary deep learning approaches still struggle to bring a useful improvement in the field of drug discovery because of the challenges of sparse, noisy, and heterogeneous data that are typically encountered in this context. We use a state-of-the-art deep learning method, Alchemite, to impute data from drug discovery projects, including multitarget biochemical activities, phenotypic activities in cell-based assays, and a variety of absorption, distribution, metabolism, and excretion (ADME) endpoints. The resulting model gives excellent predictions for activity and ADME endpoints, offering an average increase in R2 of 0.22 versus quantitative structure–activity relationship methods. The model accuracy is robust to combining data across uncorrelated endpoints and projects with different chemical spaces, enabling a single model to be trained for all compounds and endpoints. We demonstrate improvements in accuracy on the latest chemistry and data when updating models with new data as an ongoing medicinal chemistry project progresses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847 · cited 1×
“19 Meanwhile, realizing the goal of a fully generalized deep learning quantitative structure − activity relationship (QSAR) model that can be applied to general pharmaceutical project data, on both large and small scales, with minimal human intervention, has not received the same degree of…”
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
Mayr, A., Klambauer, G., Unterthiner, T., Steijaert, M., Wegner, J. K., Ceulemans, H., Clevert, D.-A., & Hochreiter, S. (2018) · Chemical Science · doi:10.1039/c8sc00148k · Cited by 584
MolGAN: An implicit generative model for small molecular graphs
De Cao, N., & Kipf, T. (2018) · arXiv · doi:10.48550/arxiv.1805.11973 · Cited by 442
Cited by
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Artificial intelligence-powered electronic skin
Xu, C., Solomon, S. A., & Gao, W. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00760-z · Cited by 259
“As most data from material experiments are discrete and noisy with high variance, it is necessary to preprocess the data through interpolating missing data and rebalancing biased training sets 89,90 .”
Enhancing preclinical drug discovery with artificial intelligence
Vijayan, R. S. K., Kihlberg, J., Cross, J. B., & Poongavanam, V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.023 · Cited by 180
“28 Deep imputation methods combine DL and statistical imputation methods to learn correlations between experimental endpoints and gain valuable information, even from minimal experimental data, to more accurately fi ll in missing experimental values.”
BackgroundMethodTse, E. G., Aithani, L., Anderson, M., Cardoso-Silva, J., Cincilla, G., Conduit, G. J., Galushka, M., Guan, D., Hallyburton, I., Irwin, B. W. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00313 · Cited by 18
Self-citation
Metadata
- Authors
- Irwin, B. W. J., Levell, J. R., Whitehead, T. M., Segall, M. D., & Conduit, G. J.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-01
- Volume
- 60
- Issue
- 6
- Pages
- 2848-2857
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W3029333120
- Cited by
- 59
- References
- 16
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.